• Users Online: 39173
  • Home
  • Print this page
  • Email this page

    Article Cited by others

SYMPOSIUM

Pegaptanib sodium for ocular vascular disease

Shukla Dhananjay, Namperumalsamy Perumalsamy, Goldbaum Mauro, Cunningham Jr Emmett T

Year : 2007| Volume: 55| Issue : 6 | Page no: 427-430

   This article has been cited by
 
1 To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors
Debroop Basu, Riya Pal, Maitrayee Sarkar, Soubhik Barma, Sumit Halder, Harekrishna Roy, Sisir Nandi, Asmita Samadder
Current Topics in Medicinal Chemistry. 2023; 23(30): 2877
[Pubmed]  [Google Scholar] [DOI]
2 Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges
Anna Hau-Yee Kong, Aston Jiaxi Wu, Olivia Ka-Yi Ho, Maggie Ming-Ki Leung, Alexis Shiying Huang, Yuanyuan Yu, Ge Zhang, Aiping Lyu, Min Li, King-Ho Cheung
International Journal of Molecular Sciences. 2023; 24(14): 11780
[Pubmed]  [Google Scholar] [DOI]
3 Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection
Esinam E. Agbosu, Scott Ledger, Anthony D. Kelleher, Jing Wen, Chantelle L. Ahlenstiel
Pharmaceutics. 2022; 14(7): 1352
[Pubmed]  [Google Scholar] [DOI]
4 Radiation retinopathy intricacies and advances in management
Noraliz García-O’Farrill, Sangeethabalasri Pugazhendhi, Peter A. Karth, Allan A. Hunter
Seminars in Ophthalmology. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Identification of Key Genes and Pathways in Persistent Hyperplastic Primary Vitreous of the Eye Using Bioinformatic Analysis
Derin M. Thomas, Chitra Kannabiran, D. Balasubramanian
Frontiers in Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
6 Exosomes as natural delivery carriers for programmable therapeutic nucleic acid nanoparticles (NANPs)
Weina Ke, Kirill A. Afonin
Advanced Drug Delivery Reviews. 2021; 176: 113835
[Pubmed]  [Google Scholar] [DOI]
7 Aptamers in biomedicine: Selection strategies and recent advances
Geanina ?tefan, Oana Hosu, Karolien De Wael, María Jesús Lobo-Castańón, Cecilia Cristea
Electrochimica Acta. 2021; 376: 137994
[Pubmed]  [Google Scholar] [DOI]
8 Role of small interfering RNA (siRNA) in targeting ocular neovascularization: A review
Shibani Supe, Archana Upadhya, Kavita Singh
Experimental Eye Research. 2021; 202: 108329
[Pubmed]  [Google Scholar] [DOI]
9 Molecular Simulations of PEGylated Biomolecules, Liposomes, and Nanoparticles for Drug Delivery Applications
Hwankyu Lee
Pharmaceutics. 2020; 12(6): 533
[Pubmed]  [Google Scholar] [DOI]
10 Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities
Fatemeh Farjadian, Amir Ghasemi, Omid Gohari, Amir Roointan, Mahdi Karimi, Michael R Hamblin
Nanomedicine. 2019; 14(1): 93
[Pubmed]  [Google Scholar] [DOI]
11 The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy
Rui Zhang, Xin Sun, Bo Niu
Experimental and Therapeutic Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
12 In vitro and ex vivo selection procedures for identifying potentially therapeutic DNA and RNA molecules
Marton, S., Reyes-Darias, J.A., Sánchez-Luque, F.J., Romero-López, C., Berzal-Herranz, A.
Molecules. 2010; 15(7): 4610-4638
[Pubmed]  [Google Scholar]
13 Current strategies to improve the efficacy and the delivery of nucleic acid based drugs
Grassi, M., Cavallaro, G., Scirč, S., Scaggiante, B., Dapas, B., Farra, R., Baiz, D., (...), Grassi, G.
Current Signal Transduction Therapy. 2010; 5(2): 92-120
[Pubmed]  [Google Scholar]
14 Anti-vascular endothelial growth factor therapies for retinal vein occlusion | [Retina ven tikanikliǧinda anti-vasküler endotelyal büyüme faktörü tedavileri]
Güler, M., Yilmaz, T., Certel, I., Önder, H.I.
Retina-Vitreus. 2010; 18(1): 77-83
[Pubmed]  [Google Scholar]
15 Use of pegaptanib in the treatment of vitreous haemorrhage in idiopathic retinal vasculitis
D Mitry,C Schmoll,V Hegde,S Borooah,J Singh,H Bennett
Eye. 2008; 22(11): 1449
[Pubmed]  [Google Scholar] [DOI]
16 Use of pegaptanib in the treatment of vitreous haemorrhage in idiopathic retinal vasculitis
Mitry, D. and Schmoll, C. and Hegde, V. and Borooah, S. and Singh, J. and Bennett, H.
Eye. 2008; 22(11): 1449-1450
[Pubmed]  [Google Scholar]
17 Current management of retinal vein occlusions
Colyer, M.H., Lai, M.M.
Techniques in Ophthalmology. 2008; 6(2): 53-59
[Pubmed]  [Google Scholar]
18 Progress of the drug therapy in corneal neovascularization
Li, L., Xi, X.-H.
International Journal of Ophthalmology. 2008; 8(4): 807-809
[Pubmed]  [Google Scholar]
19 Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis
Vianna, R.N.G., Squeri, G., Turquetti, R., Brasil, O.F.M., Burnier Jr., M.N.
Canadian Journal of Ophthalmology. 2008; 43(4): 492-493
[Pubmed]  [Google Scholar]

 

Read this article